The National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), awarded a $257,522 Project Grant (R25DA061764) to the University of Mississippi to develop a multimodal and interdisciplinary data science training program. The program aims to enhance a diverse workforce for addiction research by providing specialized training in artificial intelligence (AI) and machine learning (ML) methods. Key program components include webinars, summer...
The National Institute on Drug Abuse (NIDA) awarded a $300,290 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the Regents of the University of Minnesota. The 3-year grant, effective August 1, 2025, will fund a summer workshop program to train graduate students and junior researchers on conducting reproducible analysis of brain imaging and genomics data to study the relationship between genetic variants, brain structure/function, and mental health outcomes....
The National Institute on Drug Abuse (NIDA) awarded a $283,968 Project Grant (CFDA 93.279 - Drug Use and Addiction Research Programs) to the Regents of the University of Michigan to build an "AI Forest" system for studying social and environmental factors that influence complex behavioral traits in a wild population of white-faced capuchin monkeys in Costa Rica. The project will leverage advanced technologies like deep learning algorithms and smart testing stations to automate data...
This Project Grant award from the National Institute on Drug Abuse (NIDA), with the official CFDA program title "Drug Use and Addiction Research Programs", is funding the development of an educational intervention to train a diverse workforce in addiction data science. The $136,320 award will support the creation of an immersive, tailored addiction data science skills course that provides hands-on training in areas such as FAIR data principles, computational analytics, and natural...
This Project Grant award of $558,668 from the National Institute on Drug Abuse (NIDA) under CFDA Program 93.279 - Drug Use and Addiction Research Programs supports research to elucidate the shared and distinct molecular mechanisms underlying the interplay between HIV, substance use disorders (SUD), and neuropsychiatric/neurodegenerative conditions. The award to Massachusetts Institute of Technology (MIT) aims to leverage single-cell transcriptomic, epigenomic, and spatial datasets along with...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $613,107.00 to the Massachusetts Institute of Technology (MIT) from January 1, 2025 to November 30, 2029. The project aims to apply a novel brain imaging method called BLUSH to study brain-wide neuroplasticity and its relationship to neural activity, structural changes, and individual behavioral variability. Specific research objectives include:...
This Project Grant award from the National Institute on Drug Abuse (NIDA), part of the NIH's Drug Use and Addiction Research Programs (CFDA 93.279), will fund a $751,043 research project at the University of Massachusetts Medical School focused on investigating the cellular and molecular mechanisms underlying the complex co-morbidity of opioid use disorder (OUD), major depressive disorder (MDD), and HIV in the human brain. The project will leverage single-cell sequencing technologies and other...
This Project Grant award of $383,521 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will fund a collaborative research project to develop the marine invertebrate Hofstenia miamia as a new model system for neuroscience research. The primary objectives are to: 1) Develop methods for quantitative measurement and analysis of the worm's behavior and its environmental interactions, including using pose estimation, fluid flow...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will fund research to investigate the role of cholinergic interneurons in the ventral tegmental area on opioid-related behaviors. The $373,181 grant, awarded on July 15, 2024 with a completion date of June 30, 2027, aims to determine whether mu-opioid receptors on cholinergic interneurons contribute to opioid reward, consumption, and withdrawal, and how...
This Project Grant award of $397,829 from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), supports the development of an AI platform to discover new therapeutics for substance use disorders (SUDs). The key products and services to be delivered include: Creating a set of curated training datasets and machine learning (ML) models to accelerate drug discovery tasks for SUDs. Identifying mechanistic targets related to the...